comparemela.com

Latest Breaking News On - Ebitda tripled under advent after - Page 1 : comparemela.com

Mankind Pharma in race with PEs to buy BSV Group at possible valuation of Rs 13,000 crore

Warburg Pincus, ChrysCapital, TPG, Blackstone, EQT, Mankind Pharma, and Dr Reddy s Laboratories are competing to acquire BSV Group, a biopharma firm specializing in women s health and critical care products, indicating a trend of consolidation in the domestic pharma sector. Mankind, Dr. Reddys, and Blackstone have evaluated BSV at different times, including before Advent s acquisition.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.